Clinical Trial Candidates Patient Recruitment Insights

While the Right-to-Try Act may appear to have a patient-centric focus, it will likely increase risk for seriously ill patients and weaken the FDA’s power to…

Patient diversity in clinical trials is improving slowly – here’s one solution that might help speed things up.

Clinical trials have a diversity problem, and it could be having a negative impact on their ability to secure FDA approval. Here’s what you need to…

Clinical trials are still struggling to recruit and retain participants, which results not only in staggering costs for trial sponsors, but also prevents patients from gaining…